Severe hypertriglyceridemia Trials in Budapest, Hungary
Conditions / Severe hypertriglyceridemia / Budapest, Hungary
Clinical trials for Severe hypertriglyceridemia investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05079919 | A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia | COMPLETED | PHASE3 |
| NCT06347003 | Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01242527 | Epanova® for Lowering Very High Triglycerides | COMPLETED | PHASE2/PHASE3 |
| NCT06880770 | Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis | RECRUITING | PHASE3 |
| NCT05852431 | To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03011450 | Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment | COMPLETED | PHASE3 |
| NCT03001817 | Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function | COMPLETED | PHASE3 |
| NCT05681351 | CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04541186 | Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia | COMPLETED | PHASE2 |
| NCT05552326 | A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia | COMPLETED | PHASE3 |